Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Publication year range
3.
Rev. méd. Minas Gerais ; 22(1)jan.-mar. 2012.
Article in Portuguese | LILACS | ID: lil-676585

ABSTRACT

O infarto com supradesnivelamento do segmento ST (IAMCSST) é uma importante causa de morbimortalidade no Brasil. O tratamento ideal para o IAMCSST depende principalmente do diagnóstico precoce e da rápida seleção de estratégia de reperfusão apropriada. A angioplastia coronária percutânea (ICP) primária é a estratégia de escolha em hospitais com serviço de hemodinâmica. Em hospitais sem esse serviço, duas estratégias de reperfusão são possíveis: transferência para ICP primária ou terapia com trombolíticos. A ICP primária apresenta melhores resultados, com redução de eventos cardiovasculares, entretanto, essa vantagem pode ser perdida, dependendo do tempo de atraso para transferência. A criação de rede de cuidado para pacientes com IAMCSST é um desafio para nosso município e pretende possibilitar o acesso à terapia de reperfusão em tempo adequado, levando em consideração as condições clínicas do paciente e do sistema de saúde em que ele é atendido.


Myocardial infarction with ST segment elevation is one of the major causes of morbimortality in Brazil. The ideal treatment for the disease depends mostly on early diagnosis and choice of adequate reperfusion strategy. Primary percutaneous coronary angioplasty (PCI) is a strategywidely adopted in hospitals that provide cardiac services, whereas hospitals without such services usually adopt either transfer for PCI or therapy with thrombolytic drugs. Primary PCI usually provides better results, reducing cardiovascular events, but this may not be effective in the event of significant transference delay. The creation of a health care network for patients with the disease is a challenge in our Municipality that can provide access to reperfusion therapy as soon as possible considering both patients? clinical conditions and health insurance.


Subject(s)
Humans , Patient-Centered Care , Myocardial Infarction/therapy , Critical Pathways , Acute Coronary Syndrome/drug therapy , Angioplasty , Fibrinolytic Agents/therapeutic use , Myocardial Infarction/history
4.
JACC Cardiovasc Interv ; 2(10): 901-8, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19850247

ABSTRACT

ST-segment elevation myocardial infarction (STEMI) is one of the greatest medical emergencies, for which organization of care has a determinant impact on patient outcomes. The purpose of this paper is to review systems of care for STEMI patients. Although primary percutaneous coronary intervention (PCI) is the preferred option for patients with STEMI, offering easy and emergent access to this procedure often remains difficult because of geographic and diverse structural difficulties. intravenous fibrinolysis, especially when administered early after symptom onset and as part of a pharmacoinvasive strategy (i.e., followed by rapid coronary angiography with PCI when necessary), offers a reasonable therapeutic option in selected cases and has yielded satisfactory clinical results. Network organization is central for optimizing patient care at the acute stage of myocardial infarction. This review describes different clinical experiences with network implementation both in Europe and in North America. In all instances, early recognition of STEMI and, particularly in the pre-hospital setting, shortening time delays is central for the achievement of optimal clinical results. Overall, the encouraging results described in the models presented here, as diverse as they might be, should be an encouragement to promote and implement regional protocols according to the specific local constraints and to monitor their effectiveness by recording simple quality indicators in ongoing registries.


Subject(s)
Angioplasty, Balloon, Coronary , Clinical Protocols , Emergency Medical Services , Health Services Accessibility , Myocardial Infarction/therapy , Outcome and Process Assessment, Health Care , Patient Care Team , Regional Health Planning , Angioplasty, Balloon, Coronary/history , Coronary Angiography , Emergency Medical Services/history , Emergency Medical Services/organization & administration , Europe , Evidence-Based Medicine , Health Services Accessibility/history , Health Services Accessibility/organization & administration , History, 20th Century , Humans , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/history , National Health Programs , North America , Organizational Objectives , Outcome and Process Assessment, Health Care/history , Patient Admission , Patient Care Team/history , Patient Care Team/organization & administration , Quality Indicators, Health Care , Randomized Controlled Trials as Topic , Regional Health Planning/history , Regional Health Planning/organization & administration , Thrombolytic Therapy/history , Time Factors , Treatment Outcome
6.
Atherosclerosis ; 207(1): 1-7, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19389675

ABSTRACT

Professor Yoshio Watanabe, who developed the WHHL rabbit, died on December 13, 2008. He had contributed to studies of lipoprotein metabolism and atherosclerosis, and to the development of hypolipidemic and/or anti-atherosclerotic compounds. WHHL rabbits show hypercholesterolemia due to deficiency of LDL receptors, and very similar lipoprotein metabolism to humans. The incidences of coronary atherosclerosis and myocardial infarction in the original WHHL rabbits were very low. After three rounds of selective breeding, the coronary plaques changed to fibroatheromas with thin fibrous caps and myocardial infarction developed spontaneously. In studies with WHHL rabbits, plaque-stabilizing effects of statins were proved. In this review, we admire his achievements and describe the history of studies using WHHL rabbits.


Subject(s)
Biomedical Research/history , Coronary Artery Disease/history , Hyperlipidemias/history , Myocardial Infarction/history , Animals , Animals, Genetically Modified , Coronary Artery Disease/drug therapy , Coronary Artery Disease/genetics , Coronary Artery Disease/metabolism , Disease Models, Animal , Drug Evaluation, Preclinical/history , History, 20th Century , History, 21st Century , Hydroxymethylglutaryl-CoA Reductase Inhibitors/history , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hyperlipidemias/complications , Hyperlipidemias/drug therapy , Hyperlipidemias/genetics , Hyperlipidemias/metabolism , Lipoproteins/metabolism , Myocardial Infarction/genetics , Myocardial Infarction/metabolism , Myocardial Infarction/prevention & control , Rabbits , Receptors, LDL/deficiency , Receptors, LDL/genetics
11.
Gac Med Mex ; 132(4): 425-9, 1996.
Article in Spanish | MEDLINE | ID: mdl-8964382

ABSTRACT

A review of some historical accounts in Medicine reveals concepts, clinical descriptions and prognosis of coronary atherosclerosis and ischemic heart disease in the recent past and in remote antiquity. Herein, the historical accounts disclosed include some concepts and terms utilized in reference to atherosclerosis: the oldest documentation of coronary atherosclerosis and myocardial infarction in Egyptian mummies; the clinical syndrome of angor pectoris in the Ebers' papyrus, as well as clinical and prognostic data in the Corpus Hippocraticum regarding possible cases of angina, infarction and sudden death. These reports give a better insight into primitive medicine in the Ancient Western World, revealing the evolving concept of atherosclerosis and the existence of this disease in humanity's remote past.


Subject(s)
Arteriosclerosis/history , Myocardial Ischemia/history , Angina Pectoris/history , Death, Sudden, Cardiac , History, 18th Century , History, 19th Century , History, 20th Century , History, Ancient , Humans , Mummies , Myocardial Infarction/history
12.
Med Secoli ; (8): 2, 1996.
Article in French | MEDLINE | ID: mdl-11625373

ABSTRACT

In Svetonius' Life of the Twelve Cesars, in Tacitus' Annals, and in Dio, Cassius' Roman History, arguments can be found for the diagnosis of myocardial infarction in the case of the Roman emperor Tiberius. After violent and repeated efforts he felt an intense thoracic pain, and from that moment he became very ill and had to be carried in a litter. The course of the disease was marked by several syncopes with apparent death, some of long duration, but with spontaneous total recovery, except for the last one (which occured when getting out of bed). Moreover, we know he had abnormalities of the pulse indicating a lethal prognosis. The most logical explanation is: myocardial infarction complicated with access of ventricular tachycardia, the last one ending in ventricular fibrillation.


Subject(s)
Myocardial Infarction/history , Ventricular Fibrillation/history , Famous Persons , History, Ancient , Humans , Rome
SELECTION OF CITATIONS
SEARCH DETAIL